Reuben Cynthia, Elgaddal Nazik, Black Lindsey I
NCHS Data Brief. 2023 Jan(462):1-8.
Sleep medications are a common treatment option for insomnia (1). Insufficient sleep is associated with many negative mental and physical health outcomes, including type 2 diabetes, heart disease, obesity, depression, and an increased risk of injury (2). The prevalence of sleep difficulties and use of sleep medication has differed between men and women (3-5). This report uses 2020 National Health Interview Survey (NHIS) data to describe the percentage of men and women who used medication for sleep, defined here as taking any medication to help fall or stay asleep most days or every day in the past 30 days, by selected sociodemographic characteristics.
睡眠药物是治疗失眠的常见选择(1)。睡眠不足与许多负面的身心健康结果相关,包括2型糖尿病、心脏病、肥胖症、抑郁症以及受伤风险增加(2)。睡眠困难的发生率和睡眠药物的使用在男性和女性之间存在差异(3 - 5)。本报告使用2020年国家健康访谈调查(NHIS)的数据,按选定的社会人口学特征描述过去30天内使用睡眠药物(此处定义为大多数日子或每天服用任何有助于入睡或保持睡眠的药物)的男性和女性的百分比。
NCHS Data Brief. 2023-1
NCHS Data Brief. 2022-6
Encephale. 2004
Am J Geriatr Psychiatry. 2018-9-14
Am J Manag Care. 1998-1
Med Sci (Basel). 2025-6-27
Int J Mol Sci. 2025-6-12
Sleep Breath. 2025-4-14
J Allergy Clin Immunol Glob. 2025-2-18
J Psychoactive Drugs. 2025-3-27
J Res Med Sci. 2024-12-31
PLOS Digit Health. 2024-11-19